These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1759169)

  • 21. Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation.
    Bavaro P; Di Girolamo G; Olioso P; Papalinetti G; Iacone A; Accorsi P; Di Bartolomeo P
    Br J Haematol; 1999 Mar; 104(4):930-1. PubMed ID: 10192465
    [No Abstract]   [Full Text] [Related]  

  • 22. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience.
    Thompson CA; Steensma DP
    Br J Haematol; 2006 Nov; 135(3):405-7. PubMed ID: 17032177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
    Viron B; Dupuy CA; Kolta A; Casadevall N
    Nephrol Dial Transplant; 2008 Jul; 23(7):2416-8. PubMed ID: 18388118
    [No Abstract]   [Full Text] [Related]  

  • 24. The (re)challenging question of erythropoiesis-stimulating agents inducing pure red cell aplasia.
    Summers S; Holdsworth S; Sharples E
    Nephrol Dial Transplant; 2008 Oct; 23(10):3053-5. PubMed ID: 18558625
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pure red cell aplasia developed during treatment with erythropoietin. Complete remission during immunosuppressive therapy].
    Høi-Hansen T; Lauritzen AM; Hansen PB
    Ugeskr Laeger; 2003 May; 165(19):2001-2. PubMed ID: 12795077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course.
    Kochethu G; Baden HS; Jaworska E; Chang J; Chopra R
    Bone Marrow Transplant; 2005 Jul; 36(1):81-2. PubMed ID: 15895117
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine dependent pure red cell aplasia: a case presentation.
    Al-Issa K; Visconte V; Rogers HJ; Dembla V; Lichtin AE; Tiu RV
    Blood Cells Mol Dis; 2015 Mar; 54(3):281-3. PubMed ID: 25488615
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone marrow transplantation for CVID-like humoral immune deficiency associated with red cell aplasia.
    Sayour EJ; Mousallem T; Van Mater D; Wang E; Martin P; Buckley RH; Barfield RC
    Pediatr Blood Cancer; 2016 Oct; 63(10):1856-9. PubMed ID: 27273469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
    Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
    Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aplastic anemia and pure red cell aplasia].
    Sawada K; Hirokawa M
    Nihon Rinsho; 2008 Mar; 66(3):505-11. PubMed ID: 18326319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pure red cell aplasia in chronic lymphatic leukemia. Successful treatment using immunosuppression].
    Svojgrová M; Slechtová J; Koza V; Panzner P; Cepelák V
    Vnitr Lek; 1990 May; 36(5):495-502. PubMed ID: 2115704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.
    Hodo Y; Tsuji K; Mizukoshi E; Yamashita T; Sakai A; Nakamoto Y; Honda M; Kaneko S
    Transpl Int; 2006 Feb; 19(2):170-1. PubMed ID: 16441367
    [No Abstract]   [Full Text] [Related]  

  • 34. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
    Roychowdhury DF; Linker CA
    Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge.
    Smalling R; Foote M; Molineux G; Swanson SJ; Elliott S
    Biotechnol Annu Rev; 2004; 10():237-50. PubMed ID: 15504708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
    Howman R; Kulkarni H
    Nephrol Dial Transplant; 2007 May; 22(5):1462-4. PubMed ID: 17314208
    [No Abstract]   [Full Text] [Related]  

  • 37. A kidney transplant patient with pure red cell aplasia: first things first!
    Deeren D
    Ann Hematol; 2011 Aug; 90(8):991-2. PubMed ID: 21107837
    [No Abstract]   [Full Text] [Related]  

  • 38. The risk of hematopoietic growth factor therapy in newborn infants.
    Zipursky A
    Pediatr Res; 2002 May; 51(5):549. PubMed ID: 11978875
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppression and immunomodulation.
    Goust JM; Stevenson HC; Galbraith RM; Virella G
    Immunol Ser; 1990; 50():481-98. PubMed ID: 2091765
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinical review of antibody-mediated pure red cell aplasia.
    Vogel S; Rossert J
    Nephrol Nurs J; 2005; 32(1):17-8, 23-6; quiz 27. PubMed ID: 15787081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.